title: Chemotherapy to Treat Heart Failure: Appropriate for Light-Chain Amyloidosis?
authors.affiliation: Cardiology Division and Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: msemigran@partners.org.
authors.forename: Marc J
authors.initials: MJ
authors.lastname: Semigran
mesh_terms: D000686:Amyloidosis; D006333:Heart Failure; D006801:Humans
keywords: bortezomib; congestive heart failure; cyclophosphamide; infiltrative cardiomyopathy; light chain; melphalan